Prevalence and Associated Dietary Factors of Rome IV Functional Gastrointestinal Disorders in Rural Western Honduras.
Diet
Dyspepsia
FODMAPs
Functional gastrointestinal disorders
Irritable bowel syndrome
Rome IV criteria
Journal
Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
26
02
2020
accepted:
24
09
2020
pubmed:
23
10
2020
medline:
30
9
2021
entrez:
22
10
2020
Statut:
ppublish
Résumé
The literature is limited regarding the prevalence of functional gastrointestinal disorders (FGIDs) in Central America, and the role of dietary factors. The Rome IV diagnostic questionnaire and National Cancer Institute Diet History questionnaire were administered in one-on-one interviews to a distributed cross section of the general adult population of Western Honduras. Our aim was to estimate prevalence of common FGIDs and symptoms and their relationships to dietary habits. In total, 815 subjects were interviewed, of whom 151 fulfilled criteria for an FGID (18.5%). Gastroduodenal FGIDs were noted in 9.4%, with epigastric pain syndrome (EPS) more common than postprandial distress syndrome, 8.5% versus 1.6%. Among bowel disorders, functional abdominal bloating (FAB) was most prevalent (6.3%), followed by irritable bowel syndrome (3.6%), functional diarrhea (FDr; 3.4%), and functional constipation (1.1%). A significant inverse association was noted between regular bean intake and any FGID (OR 0.41, 95% CI 0.27-0.63), driven by IBS and FDr. Vegetable consumption was associated with lower prevalence of functional diarrhea (OR 0.12; 95% CI 0.04-0.35) and any diarrheal disorder (OR 0.11; 95% CI 0.04-0.31). Subjects with a median daily intake of ≥ 4 corn tortillas had 1.75 (95% CI 1.22-2.50) times the odds of having any FGID. FGIDs were common in this rural low-resource setting in Central America, with an intriguing distribution of specific FGIDs. EPS and FAB were common, but IBS was not. Local dietary factors were associated with specific FGIDs, suggesting that diet may play a role in global variations of FGIDs.
Sections du résumé
BACKGROUND
The literature is limited regarding the prevalence of functional gastrointestinal disorders (FGIDs) in Central America, and the role of dietary factors.
METHODS
The Rome IV diagnostic questionnaire and National Cancer Institute Diet History questionnaire were administered in one-on-one interviews to a distributed cross section of the general adult population of Western Honduras. Our aim was to estimate prevalence of common FGIDs and symptoms and their relationships to dietary habits.
RESULTS
In total, 815 subjects were interviewed, of whom 151 fulfilled criteria for an FGID (18.5%). Gastroduodenal FGIDs were noted in 9.4%, with epigastric pain syndrome (EPS) more common than postprandial distress syndrome, 8.5% versus 1.6%. Among bowel disorders, functional abdominal bloating (FAB) was most prevalent (6.3%), followed by irritable bowel syndrome (3.6%), functional diarrhea (FDr; 3.4%), and functional constipation (1.1%). A significant inverse association was noted between regular bean intake and any FGID (OR 0.41, 95% CI 0.27-0.63), driven by IBS and FDr. Vegetable consumption was associated with lower prevalence of functional diarrhea (OR 0.12; 95% CI 0.04-0.35) and any diarrheal disorder (OR 0.11; 95% CI 0.04-0.31). Subjects with a median daily intake of ≥ 4 corn tortillas had 1.75 (95% CI 1.22-2.50) times the odds of having any FGID.
CONCLUSIONS
FGIDs were common in this rural low-resource setting in Central America, with an intriguing distribution of specific FGIDs. EPS and FAB were common, but IBS was not. Local dietary factors were associated with specific FGIDs, suggesting that diet may play a role in global variations of FGIDs.
Identifiants
pubmed: 33089482
doi: 10.1007/s10620-020-06639-y
pii: 10.1007/s10620-020-06639-y
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3086-3095Informations de copyright
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.
Références
Lin S, Mooney PD, Kurien M, Aziz I, Leeds JS, Sanders DS. Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes. Eur J Gastroenterol Hepatol. 2014;26:1176–1180.
pubmed: 25076066
doi: 10.1097/MEG.0000000000000171
Drossman DA. Functional gastrointestinal disorders: History, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150:1262–1279.
doi: 10.1053/j.gastro.2016.02.032
Buscail C, Sabate J-M, Bouchoucha M, et al. Western dietary pattern is associated with irritable bowel syndrome in the French NutriNet Cohort. Nutrients. 2017;9:986.
pmcid: 5622746
doi: 10.3390/nu9090986
pubmed: 5622746
Duncanson K, Burrows T, Walker MM, Talley NJ. Food and functional dyspepsia: a systematic Review. Gastroenterology. 2017;152:S303. https://doi.org/10.1016/S0016-5085(17)31301-X .
doi: 10.1016/S0016-5085(17)31301-X
Manning LP, Biesiekierski JR. Use of dietary interventions for functional gastrointestinal disorders. Curr Opin Pharmacol. 2018;43:132–138. https://doi.org/10.1016/j.coph.2018.09.003 .
doi: 10.1016/j.coph.2018.09.003
pubmed: 30308416
Pérez y López N, Torres-López E, Zamarripa-Dorsey F. Clinical response in Mexican patients with irritable bowel syndrome treated with a low diet low in fermentable carbohydrates (FODMAP) (English Edition). Revista de Gastroenterología de México. 2015;80:180–185. https://doi.org/10.1016/j.rgmxen.2015.08.011 .
doi: 10.1016/j.rgmxen.2015.08.011
pubmed: 26300323
Salvador Peña A, Crusius A, Bart J. Central America in transition: from maize to wheat. Challenges and opportunities. Nutrients. 2015;7:7163–7171.
doi: 10.3390/nu7095330
Schumann D, Klose P, Lauche R, Dobos G, Langhorst J, Cramer H. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Nutrition. 2018;45:24–31.
pubmed: 29129233
doi: 10.1016/j.nut.2017.07.004
Yepes IdJ, Múnera MN, Martelo C. Dieta baja en oligosacáridos, disacáridos, monosacáridos y polioles fermentables y calidad de vida en pacientes con síndrome de intestino irritable en Colombia. Biomédica. 2018;38:54–61.
doi: 10.7705/biomedica.v38i0.3594
Halder SL, Locke GR III, Schleck CD, Zinsmeister AR, Melton LJ III, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007;133:799–807.
pubmed: 17678917
doi: 10.1053/j.gastro.2007.06.010
Hungin A, Whorwell P, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther. 2003;17:643–650.
pubmed: 12641512
doi: 10.1046/j.1365-2036.2003.01456.x
Oshima T, Miwa H. Epidemiology of functional gastrointestinal disorders in Japan and in the world. J Neurogastroenterol Motil. 2015;21:320.
pubmed: 26095436
pmcid: 4496905
doi: 10.5056/jnm14165
Carter D, Beer-Gabel M, Derazne E, Tzur D, Bardan E. The severity of symptoms related to irritable bowel syndrome is a risk factor for the misclassification of significant organic disease. J Clin Gastroenterol. 2017;51:421–425.
pubmed: 27348318
doi: 10.1097/MCG.0000000000000582
Dixon-Woods M, Critchley S. Medical and lay views of irritable bowel syndrome. Fam Pract. 2000;17:108–113.
pubmed: 10758070
doi: 10.1093/fampra/17.2.108
Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71.
pubmed: 24523597
pmcid: 3921083
Chang L, Lembo A, Sultan S. American gastroenterological association institute technical review on the pharmacological management of irritable bowel syndrome. Gastroenterology. 2014;147:1149–1172.
pubmed: 25224525
doi: 10.1053/j.gastro.2014.09.002
Cornejo CZ, Villarreal JM. Relation between irritable bowel syndrome symptoms and depressive symptoms in hospitalized patients. Revista de Gastroenterologia del Peru. 2005;25:156–160.
Cortés X, Roset M, Barrull C, Sais C, Raya A. Coste del síndrome del intestino irritable con predominio de estreñimiento en España. PharmacoEcon Span Res Artic. 2016;13:1–8.
doi: 10.1007/s40277-015-0048-0
Canavan C, West J, Card T. The economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40:1023–1034.
pubmed: 25199904
doi: 10.1111/apt.12938
López-Colombo A, Morgan D, Bravo-González D, Montiel-Jarquín A, Méndez-Martínez S, Schmulson M. The epidemiology of functional gastrointestinal disorders in Mexico: a population-based study. Gastroenterol Res Pract 2012; 2012.
Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:908–917. https://doi.org/10.1016/s2468-1253(20)30217-x .
doi: 10.1016/s2468-1253(20)30217-x
pubmed: 32702295
Bujanda L, Gutiérrez-Stampa M, Caballeros C, Alkiza M, editors. Gastrointestinal disorders in Guatemala and their relation with parasitic infections. Anales de Medicina Interna (Madrid, Spain: 1984); 2002.
Campos GH, Villareal JM, Cornejo CZ, León RB. Prevalence of Manning’s symptoms in a Lima upper socioeconomic level population. Revista de Gastroenterologia del Peru. 2001;21:301–305.
Schmulson M, Adeyemo M, Gutiérrez-Reyes G, et al. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol. 2010;105:925.
pubmed: 20179693
doi: 10.1038/ajg.2010.58
Schmulson M, Ortíz O, Santiago-Lomeli M, et al. Frequency of functional bowel disorders among healthy volunteers in Mexico City. Dig Dis. 2006;24:342–347.
pubmed: 16849861
doi: 10.1159/000092887
Schmulson M, Vargas J, López-Colombo A, Remes-Troche J, López-Alvarenga J. Prevalence and clinical characteristics of the IBS subtypes according to the Rome III criteria in patients from a clinical, multicentric trial. A report from the Mexican IBS Working Group. Revista de Gastroenterologia de Mexico.. 2010;75:427–438.
pubmed: 21169110
Becker-Dreps S, Morgan D, Peña R, Cortes L, Martin CF, Valladares E. Association between intimate partner violence and irritable bowel syndrome: a population-based study in Nicaragua. Violence Against Women. 2010;16:832–845.
pubmed: 20558772
pmcid: 3127242
doi: 10.1177/1077801210374816
Morgan DR, Benshoff M, Cáceres M, et al. Irritable bowel syndrome and gastrointestinal parasite infection in a developing nation environment. Gastroenterol Res Pract. 2012;2012:343812. https://doi.org/10.1155/2012/343812 .
doi: 10.1155/2012/343812
pubmed: 22474433
pmcid: 3296149
Schmulson M. Is post infection-irritable bowel syndrome less frequent in Mexico? Am J Gastroenterol. 2019;114:846–848. https://doi.org/10.14309/ajg.0000000000000098 .
doi: 10.14309/ajg.0000000000000098
pubmed: 30848734
Porras R, López-Colombo A, Schmulson M. Incremento en las publicaciones científicas sobre síndrome de intestino irritable en México y Latinoamérica. Revista de Gastroenterologia de Mexico. 2015;80:228–235.
pubmed: 26271445
doi: 10.1016/j.rgmx.2015.06.007
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712–721. https://doi.org/10.1016/j.cgh.2012.02.029 .
doi: 10.1016/j.cgh.2012.02.029
pubmed: 22426087
Piñeros M, Frech S, Frazier L, Laversanne M, Barnoya J, et al. Advancing reliable data for cancer control in the Central America four Region. J Glob Oncol. 2018;4:1–11. https://doi.org/10.1200/JGO.2016.008227 .
doi: 10.1200/JGO.2016.008227
pubmed: 30241245
Censo de Población XVII y Vivienda VI. Instituto Nacional de Estadistica. 2013. http://170.238.108.227/binhnd/RpWebEngine.exe/Portal . Accessed 9/1/2019.
Palsson OS, Whitehead WE, Chang L, Chey W, Crowell M, Keefer L et al. Rome IV diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology. 2016.
Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. Rome Foundation, 2017.
Subar AF, Thompson FE, Kipnis V, et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America’s Table Study. Am J Epidemiol. 2001;154:1089–1099.
pubmed: 11744511
doi: 10.1093/aje/154.12.1089
Dominguez L, Norwood D, Paredes A, et al. Trastornos Funcionales de Motilidad Intestinal en Adultos Diagnosticados Mediante Rome-IV. Rev Med Honduras. 2019;87:S1–S106.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
pubmed: 18929686
doi: 10.1016/j.jbi.2008.08.010
Menchú MT, Méndez H. Tabla de composición de alimentos de Centroamérica. Menchú and Mendez, Guatemala City. INCAP, OPS; 2007.
Muir JG, Rose R, Rosella O, et al. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem. 2009;57:554–565.
pubmed: 19123815
doi: 10.1021/jf802700e
Tuck C, Ly E, Bogatyrev A, et al. Fermentable short chain carbohydrate (FODMAP) content of common plant-based foods and processed foods suitable for vegetarian-and vegan-based eating patterns. J Hum Nutri Diet. 2018;31:422–435.
doi: 10.1111/jhn.12546
Biesiekierski JR, Rosella O, Rose R, et al. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet. 2011;24:154–176. https://doi.org/10.1111/j.1365-277x.2010.01139.x .
doi: 10.1111/j.1365-277x.2010.01139.x
pubmed: 21332832
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries. Am J Gastroenterol. 2018;113:86.
pubmed: 29134969
doi: 10.1038/ajg.2017.421
Schlemper R, Werf SVD, Vandenbroucke J, Biemond I, Lamers C. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in the Netherlands and Japan. Scand J Gastroenterol. 1993;28:33–41.
doi: 10.3109/00365529309101573
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018;3:252–262. https://doi.org/10.1016/S2468-1253(18)30003-7 .
doi: 10.1016/S2468-1253(18)30003-7
pubmed: 29396034
Hirakawa K, Adachi K, Amano K, et al. Prevalence of non-ulcer dyspepsia in the Japanese population. J Gastroenterol Hepatol. 1999;14:1083–1087.
pubmed: 10574135
doi: 10.1046/j.1440-1746.1999.02012.x
Kumano H, Kaiya H, Yoshiuchi K, Yamanaka G, Sasaki T, Kuboki T. Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. Am J Gastroenterol. 2004;99:370.
pubmed: 15046231
doi: 10.1111/j.1572-0241.2004.04048.x
Manabe N, Haruma K. Diagnosis and treatment of dyspeptic patients in Japan. J Gastroenterol Hepatol. 2011;26:27–31.
pubmed: 21443704
doi: 10.1111/j.1440-1746.2011.06628.x
Schmulson M. Heartburn according to Rome II in Spanish-Mexico: Gastroesophageal reflux must be ruled out. Rev Gastroenterol Mex. 2009;74:74–76.
pubmed: 19666329
Sander GB, Francisconi CFdM, Mazzoleni LE, Lopes MHI, Silva OBd, Madi J. An unexpected high prevalence of non-investigated dyspepsia in Brasil: a population-based study. Revista HCPA Porto Alegre, RS. 2007.
Ford AC, Lacy BE, Talley NJ. Irritable Bowel Syndrome. New England Journal of Medicine.. 2017;376:2566–2578. https://doi.org/10.1056/NEJMra1607547 .
doi: 10.1056/NEJMra1607547
Valerio-Urena J, Vásquez-Fernández F, Jiménez-Pineda A, et al. Prevalence of irritable bowel syndrome in Veracruz City, Mexico: a community-based survey. Revista de Gastroenterologia de Mexico. 2010;75:36–41.
pubmed: 20423781
Veitia G, Pernalete B, Cachima L, et al. Prevalencia del síndrome intestino irritable en la población adulta venezolana. Gen. 2013;67:139–144.
Álvarez DFG, Vargas JGM, Medina LMAR, Oviedo SCM, López PAC, Jaimes GER. Factores sociosanitarios y prevalencia del síndrome del intestino irritable según los criterios diagnósticos de Roma III en una población general de Colombia. Gastroenterol Hepatol. 2009;32:395–400.
doi: 10.1016/j.gastrohep.2009.01.177
Gonzales Gamarra RG, Ruiz Sánchez JG, León Jiménez F, Cubas Benavides F, Díaz Vélez C. Prevalencia del Sindrome de Intestino Irritable en la Población Adulta de Chiclayo durante el año 2011. Revista de Gastroenterología del Perú. 2012;32:381–386.
pubmed: 23307088
Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582.
pubmed: 21606976
doi: 10.1038/ajg.2011.164
Wu M, Zhao Y, Wang R, et al. Epidemiology of Functional Abdominal Bloating and Its Impact on Health Related Quality of Life: Male-Female Stratified Propensity Score Analysis in a Population Based Survey in Mainland China. PloS One.. 2014;9:e102320.
pubmed: 25036100
pmcid: 4103840
doi: 10.1371/journal.pone.0102320
Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: A double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011;106:508–514. https://doi.org/10.1038/ajg.2010.487 .
doi: 10.1038/ajg.2010.487
pubmed: 21224837
Elli L, Tomba C, Branchi F, et al. Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: results from a multicenter randomized double-blind placebo-controlled gluten challenge. Nutrients. 2016;8:84.
pubmed: 26867199
pmcid: 4772047
doi: 10.3390/nu8020084
Skodje GI, Sarna VK, Minelle IH, et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology. 2018;154:529–539. https://doi.org/10.1053/j.gastro.2017.10.040 .
doi: 10.1053/j.gastro.2017.10.040
pubmed: 29102613
Francisconi CF, Sperber AD, Fang X, et al. Multicultural aspects in functional gastrointestinal disorders (FGIDs). Gastroenterology. 2016;150:1344–1354.
doi: 10.1053/j.gastro.2016.02.013
Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol Q Publ Hell Soc Gastroenterol. 2015;28:203.
Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley N. The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61:1284–1290.
pubmed: 22234979
doi: 10.1136/gutjnl-2011-300474
Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R. A population study of food intolerance. The Lancet. 1994;343:1127–1130. https://doi.org/10.1016/S0140-6736(94)90234-8 .
doi: 10.1016/S0140-6736(94)90234-8